TBCRC 033: A randomized phase II study of adjuvant trastuzumab emtansine (T-DM1) vs paclitaxel (T) in combination with trastuzumab (H) for stage I HER2-positive breast cancer (BC) (ATEMPT) Meeting Abstract
| Authors: | Tolaney, S. M.; Trippa, L.; Barry, W.; Hu, J.; Dang, C.; Yardley, D.; Isakoff, S.; Valero, V.; Faggen, M.; Mulvey, T.; Bose, R.; Weckstein, D.; Wolff, A.; Reeder-Hayes, K.; Rugo, H.; Ramaswamy, B.; Zuckerman, D.; Hart, L.; Gadi, V. K.; Constantine, M.; Cheng, K.; Briccetti, F.; Schneider, B.; Garrett, M.; Marcom, K.; Albain, K.; DeFusco, P.; Tung, N.; Ardman, B.; Nanda, R.; Jankowitz, R.; Demeo, M.; Partridge, A.; Burstein, H.; Winer, E. P.; Krop, I. |
| Abstract Title: | TBCRC 033: A randomized phase II study of adjuvant trastuzumab emtansine (T-DM1) vs paclitaxel (T) in combination with trastuzumab (H) for stage I HER2-positive breast cancer (BC) (ATEMPT) |
| Meeting Title: | 42nd Annual San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 80 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2019 Dec 10-14 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2020-02-01 |
| Language: | English |
| ACCESSION: | WOS:000527012500028 |
| DOI: | 10.1158/1538-7445.Sabcs19-gs1-05 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: GS1-05 -- Source: Wos |
